Manganese enhances the anti-tumor function of CD8+T cells via inducing type I interferon in hepatocellular carcinoma

Manganese enhances the anti-tumor function of CD8+T cells via inducing type I interferon in hepatocellular carcinoma

Saved in:

書目詳細資料
Main Authors:	SONG YUAN, LIU YONGHAO, TEO HUEY YEE, Zuhairah Binte Hanafi, MEI YU, ZHU YING, CHUA YEN LEONG, Lv Mengze, Jiang Zhengfan, LIU HAIYAN
其他作者:	MICROBIOLOGY AND IMMUNOLOGY
格式:	Article
語言:	English
出版:	cellular & molecular immunology 2021
主題:	Manganese, CD8+ T cells, type I interferon, hepatocellular carcinoma
在線閱讀:	https://scholarbank.nus.edu.sg/handle/10635/188580
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

相似書籍

Inhibition of CD44 expression in hepatocellular carcinoma cells enhances apoptosis, chemosensitivity, and reduces tumorigenesis and invasion
由: Xie, Z., et al.
出版: (2011)

The regulation of human manganese superoxide dismutase gene
由: Sureerut Pornatadavity
出版: (2023)

Manganese enhances the antitumor function of CD8+T cells by inducing type I interferon production
由: SONG YUAN, et al.
出版: (2021)

Global epidemiology and genetics of hepatocellular carcinoma
由: Toh, Ming Ren, et al.
出版: (2023)

Up-regulation of C/EBPa in hepatocellular carcinoma is correlated to poorer prognosis
由: ANG YANG HUEY JESSICA
出版: (2013)

Circulating markers for prognosis of hepatocellular carcinoma
由: Wong, K.-F., et al.
出版: (2014)

Targeted inhibition of purine metabolism is effective in suppressing hepatocellular carcinoma progression
由: Chong, Yong Chun, et al.
出版: (2020)

Prognosis prediction of hepatocellular carcinoma based on magnetic resonance imaging features
由: Low, Hsien Min, et al.
出版: (2023)

Utilizing experimental mouse model to identify effectors of hepatocellular carcinoma induced by HBx antigen
由: Yang, M.-H., et al.
出版: (2021)

Diagnostic utility of immunohistochemistry in hepatocellular carcinoma, its variants and their mimics
由: Wee, A.
出版: (2012)

ABERRANT DNA METHYLATION IN HEPATOCELLULAR CARCINOMA
由: MAH WAY CHAMP
出版: (2014)

Value of alpha-foetoprotein for screening of recurrence in hepatocellular carcinoma post resection
由: Chang, S.K.Y., et al.
出版: (2014)

First-line Systemic Therapies for Advanced Hepatocellular Carcinoma: A Systematic Review and Patient-Level Network Meta-Analysis
由: Fong K.Y., et al.
出版: (2022)

Combined hepatocellular-cholangiocarcinoma: Diagnostic challenge in hepatic fine needle aspiration biopsy
由: Wee, A., et al.
出版: (2012)

Targeting PPAR-gamma counteracts tumour adaptation to immune-checkpoint blockade in hepatocellular carcinoma
由: Xiong, Zhewen, et al.
出版: (2023)

Radioembolization after portal vein embolization in a patient with multifocal hepatocellular carcinoma
由: Burgmans, M.C., et al.
出版: (2014)

The Role of Interferon Gamma in Regulating Antigen Specific CD8 T Cell Responses in a Mouse Model of Influenza
由: NAYANA PRABHU PADUBIDHRI
出版: (2013)

Imaging of hepatocellular carcinoma: Diagnosis, staging and treatment monitoring
由: Hennedige, T., et al.
出版: (2016)

Diabetes mellitus and risk of hepatocellular carcinoma: Findings from the Singapore Chinese Health Study
由: Koh, W.-P., et al.
出版: (2014)

Expressions of SE-1, CD31 and CD105 in the vascular endothelial cells and serum of rat with hepatocellular carcinoma
由: Wang, J.-Y., et al.
出版: (2014)

Metabolic alterations and vulnerabilities in hepatocellular carcinoma
由: Tenen, Daniel G., et al.
出版: (2022)

Validation of plasma membrane proteins expressed in invading hepatocellular carcinoma
由: Patamaporn Molee, et al.
出版: (2015)

Manganese mining
由: Fernandez, Rico Jose F.
出版: (1976)

p53 expression in hepatocellular carcinoma in a population in Singapore with endemic hepatitis B virus infection
由: Wee, A., et al.
出版: (2016)

Hepatitis B virus infection contributes to oxidative stress in a population exposed to aflatoxin B1 and high-risk for hepatocellular carcinoma
由: Liu, Z.-M., et al.
出版: (2011)

Resection for hepatocellular carcinoma: Is it justifiable to restrict this to the American Association for the Study of the Liver/Barcelona Clinic for Liver Cancer criteria?
由: Chow, P.K.-H.
出版: (2014)

Proteome database of hepatocellular carcinoma.
由: LIANG, Cynthia, et al.
出版: (2002)

Highly well differentiated hepatocellular carcinoma and benign hepatocellular lesions: Can they be distinguished on fine needle aspiration biopsy?
由: Wee, A., et al.
出版: (2016)

DECIPHERING THE ROLE OF PITPNA ANTISENSE RNA 1 (PITPNA-AS1) IN HEPATOCELLULAR CARCINOMA
由: LEONG KA WAI
出版: (2021)

DESIGNING ANTI-PDL1 ANTIBODY CONJUGATED POLYMERIC COACERVATES AS A NOVEL “NANO-IMMUNOTHERAPY” AGAINST HEPATOCELLULAR CARCINOMA
由: CHERYLETTE ANNE ALEXANDER
出版: (2023)

The Roles of Histone Deacetylases 1 and 2 in Hepatocellular carcinoma
由: LEUNG HO WING, CAROL
出版: (2012)

RAS AND RHO COREGULATE LIVER DEVELOPMENT AND HEPATOCELLULAR CARCINOMA IN ZEBRAFISH
由: CHEW TI WENG
出版: (2012)

Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma
由: Lee, S.-C., et al.
出版: (2012)

TLR3 induces Hepatocellular carcinoma cell death and increases natural killer cell activity
由: TOW TINGTING, CHARLENE
出版: (2011)

Real-World Data on the Diagnosis, Treatment, and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT Study
由: Chow, Pierce K.H., et al.
出版: (2024)

PROTEOMICS IDENTIFICATION AND CHARACTERIZATION OF NOVEL BIOMARKERS ASSOCIATED WITH RECURRENCE OF HEPATOCELLULAR CARCINOMA
由: LEE SEOW CHONG
出版: (2016)

Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients
由: Chew, V., et al.
出版: (2014)

Biodegradable polymers as a noncoding miRNA nanocarrier for multiple targeting therapy of human hepatocellular carcinoma
由: Yang, Chengbin, et al.
出版: (2021)

Emodin inhibits growth and induces apoptosis in an orthotopic hepatocellular carcinoma model by blocking activation of STAT3
由: Subramaniam, A., et al.
出版: (2014)

MicroRNA-122 as a regulator of mitochondrial metabolic gene network in hepatocellular carcinoma
由: Burchard, J., et al.
出版: (2014)